Related references
Note: Only part of the references are listed.Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation
Alok A. Khorana et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
Lucia Mazzolai et al.
EUROPEAN HEART JOURNAL (2018)
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
Michael B. Streiff et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
Chatree Chai-Adisaksopha et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
Andres J. Munoz Martin et al.
BRITISH JOURNAL OF CANCER (2018)
Pharmacokinetic variability of anticoagulants in patients with cancer associated thrombosis: Clinical consequences
Audrey Bellesoeur et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Physicians' decision about long-term thromboprophylaxis in cancer outpatients: CAT AXIS, a case vignette study on clinical practice in France
Florian Scotte et al.
SUPPORTIVE CARE IN CANCER (2018)
Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry
Corinne Frere et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future
Alok A. Khorana et al.
THROMBOSIS RESEARCH (2018)
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)
Dominique Farge et al.
Oncotarget (2018)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions
Hanno Riess et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study
Noemie Kraaijpoel et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study
Giancarlo Agnelli et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Anticoagulation for the long-termtreatment of venous thromboembolism in people with cancer
Lara A. Kahale et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria
George Dranitsaris et al.
SUPPORTIVE CARE IN CANCER (2017)
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry
Adriano Alatri et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Apixaban and dalteparin in active malignancy associated venous thromboembolism
Robert McBane et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Luis Jara-Palomares et al.
THROMBOSIS RESEARCH (2017)
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial
Alok A. Khorana et al.
THROMBOSIS RESEARCH (2017)
Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis
Alok A. Khorana et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2017)
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site
Isabelle Mahe et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer
Tom van der Hulle et al.
CHEST (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis
I. Mahe et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2016)
Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study
F. Cajfinger et al.
THROMBOSIS RESEARCH (2016)
Predictors of recurrent venous thromboembolism and bleeding on anticoagulation
Laurel A. Menapace et al.
THROMBOSIS RESEARCH (2016)
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
Gary E. Raskob et al.
LANCET HAEMATOLOGY (2016)
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Marcello Di Nisio et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Direct Oral Anticoagulants in Patients With VTE and Cancer A Systematic Review and Meta-analysis
Maria Cristina Vedovati et al.
CHEST (2015)
Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology
Simon Noble et al.
HAEMATOLOGICA (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
Uwe Pelzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study
C. W. Francis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
G. Agnelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Isabelle Mahe et al.
PLOS ONE (2015)
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology
Simon Noble et al.
HAEMATOLOGICA (2015)
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
Cheng E. Chee et al.
BLOOD (2014)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Stavros V. Konstantinides et al.
EUROPEAN HEART JOURNAL (2014)
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism
T. van der Hulle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
New Oral Anticoagulants and the Cancer Patient
Nicholas J. Short et al.
ONCOLOGIST (2014)
Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer
Carlos Martinez et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis
Marc Carrier et al.
THROMBOSIS RESEARCH (2014)
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Martin H. Prins et al.
LANCET HAEMATOLOGY (2014)
Implementing Thrombosis Guidelines in Cancer Patients: A Review
Dominique Farge-Bancel et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2014)
Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis
P. L. Den Exter et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D. Farge et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
Gary H. Lyman et al.
ONCOLOGIST (2013)
Validation of the clinical prediction rule for recurrent venous thromboembolism in cancer patients: the Ottawa score
Shin Ahn et al.
SUPPORTIVE CARE IN CANCER (2013)
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
Martha L. Louzada et al.
CIRCULATION (2012)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A. Maraveyas et al.
EUROPEAN JOURNAL OF CANCER (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
M. N. Levine et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
Harry R. Buller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
M. Mandala et al.
ANNALS OF ONCOLOGY (2011)
Venous Thromboembolic Disease
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism - Findings from the RIETE Registry
Javier Trujillo-Santos et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Venous thromboembolism in the outpatient setting
Frederick A. Spencer et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Share Paper
